BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3488894)

  • 1. Emergence of resistance in gram-negative bacteria: a risk of broad-spectrum beta-lactam use.
    Dworzack DL
    Drug Intell Clin Pharm; 1986; 20(7-8):562-7. PubMed ID: 3488894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and clinical significance of resistance to new beta-lactam antibiotics.
    Livermore DM; Wood MJ
    Br J Hosp Med; 1990 Oct; 44(4):252-8, 261-3. PubMed ID: 2249100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms by which imipenem may overcome resistance in gram-negative bacilli.
    Williams RJ; Yang YJ; Livermore DM
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():9-13. PubMed ID: 3493237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responses.
    Pechère JC
    Drugs; 1988; 35 Suppl 2():22-8. PubMed ID: 3260854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to beta-lactams in gram-negative bacteria: relative contributions of beta-lactamase and permeability limitations.
    Nayler JH
    J Antimicrob Chemother; 1987 Jun; 19(6):713-32. PubMed ID: 3301784
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance.
    Malouin F; Bryan LE
    Antimicrob Agents Chemother; 1986 Jul; 30(1):1-5. PubMed ID: 3530121
    [No Abstract]   [Full Text] [Related]  

  • 7. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to beta-lactam antibiotics in anaerobic bacteria.
    Nord CE; Hedberg M
    Rev Infect Dis; 1990; 12 Suppl 2():S231-4. PubMed ID: 2406875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
    Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
    J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
    Neu HC; Chin NX
    Chemioterapia; 1985 Feb; 4(1):63-70. PubMed ID: 3872725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of resistance of enterococci to beta-lactam antibiotics.
    Fontana R; Canepari P; Lleò MM; Satta G
    Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):103-5. PubMed ID: 2180705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaerobic bacteria and beta-lactam antibiotics.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 42():72-82. PubMed ID: 6335601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of permeability barriers in resistance to beta-lactam antibiotics.
    Nikaido H
    Pharmacol Ther; 1985; 27(2):197-231. PubMed ID: 2412244
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of beta-lactam resistance in Haemophilus influenzae.
    Gutmann L; Williamson R; Collatz E; Acar JF
    Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):610-5. PubMed ID: 3143572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative relationship between sensitivity to beta-lactam antibiotics and beta-lactamase production in gram-negative bacteria--II. Non-steady-state treatment and progress curves.
    Frère JM; Joris B; Crine M; Martin HH
    Biochem Pharmacol; 1989 May; 38(9):1427-33. PubMed ID: 2655602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
    Tsuji A
    Nihon Rinsho; 1991 Oct; 49(10):2254-60. PubMed ID: 1749080
    [No Abstract]   [Full Text] [Related]  

  • 18. [Penicillin--binding protein: the target for beta-lactam antibiotics, beta-lactamases and their inhibitors].
    Lessel J
    Pharm Unserer Zeit; 1996 Jan; 25(1):17-27. PubMed ID: 8882750
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergism and antagonism in double beta-lactam antibiotic combinations.
    Gutmann L; Williamson R; Kitzis MD; Acar JF
    Am J Med; 1986 May; 80(5C):21-9. PubMed ID: 3487247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of structural properties of beta-lactam antibiotics to antibacterial activity.
    Neu HC
    Am J Med; 1985 Aug; 79(2A):2-13. PubMed ID: 3895915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.